Join us at our Satellite Symposium on June 14th at 8:15am CEST at the #EULAR2024 Congress in Vienna, Austria. We will have presentations from Georg Schett, a pioneer of CAR T cell therapy for the treatment of autoimmune diseases, and Carl June, a pioneer of the first CAR T cell therapy approved in oncology, as well as David J. Chang, MD, MPH, FACR, our Chief Medical Officer, sharing our initial clinical data with CABA-201 in myositis and lupus. Look forward to seeing you there! #EULAR2024 #CART #celltherapy #autoimmune
Cabaletta Bio’s Post
More Relevant Posts
-
Read the latest Oncotarget #announcements and #pressreleases: https://lnkd.in/dd39jgy #openaccess #peerreviewed #oncology #cancer #researchpapers
-
Read the latest Oncotarget #announcements and #pressreleases: https://lnkd.in/dd39jgy #openaccess #peerreviewed #oncology #cancer #researchpapers
In the News | Oncotarget
oncotarget.com
-
Read the latest Oncotarget #announcements and #pressreleases: https://lnkd.in/dd39jgy #openaccess #peerreviewed #oncology #cancer #researchpapers
In the News | Oncotarget
oncotarget.com
-
We would like to congratulate Rebekah Yu and the co-authors on their manuscript "Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groups," a collaboration with Merck that has been published in Cancer Medicine This analysis of medical records from the ConcertAI Oncology Dataset unveiled insights into characteristics, post-nephrectomy outcomes, and patient journeys in the United States. Findings showed promising survival rates for intermediate-high- and high-risk RCC patients, highlighting the potential benefits of new therapeutic options. Read the full manuscript: https://hubs.ly/Q02BLGQw0 #RCCResearch #NephrectomyJourney #CancerOutcomes #MedicalAdvancements
-
-
Tomorrow is Glioblastoma Awareness Day. According to the Brain Tumour Foundation of Canada, the incidence of glioblastoma (GB), also known as glioblastoma multiforme, is 4 per 100,000 people in Canada. There's growing evidence that cannabis and its derivatives may be effective in treating cancer, including glioblastoma multiforme. Visit our learning centre for up-to-date research! https://buff.ly/3NVmDDK #glioblastomaawarenessday #medicalcannabis
-
-
#Paper | Recommendations for the Equitable and Widespread Implementation of #LiquidBiopsy for Cancer Care American Society of Clinical Oncology (ASCO) Access the entire article here 👇
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care
ascopubs.org
-
Read the latest Oncotarget #announcements and #pressreleases: https://lnkd.in/dd39jgy #openaccess #peerreviewed #oncology #cancer #researchpapers
In the News | Oncotarget
oncotarget.com
-
Read the latest Oncotarget #announcements and #pressreleases: https://lnkd.in/dd39jgy #openaccess #peerreviewed #oncology #cancer #researchpapers
In the News | Oncotarget
oncotarget.com
-
Expert Conversations on Metastatic Colorectal Cancer Circulating Tumor DNA, an Emerging Prognostic Marker Heather Greene, MSN, FNP, AOCNP, and Kevin Krise, MPA, PA-C, discuss the role that ctDNA plays in improving treatment for patients with mCRC and the ways that testing for ctDNA can help inform a care team when a patient’s imaging isn’t telling the whole story. They share how their practices determine when to use ctDNA testing, how they explain its uses and limitations to their patients, and what NCCN guidelines say about the usefulness of this testing.
JADPRO Expert Conversations
conversations.advancedpractitioner.com
-
Delve into another one of our articles, “Radioisotopes and Their Future in Medicine”. Gain insight into how these tools reshape cancer treatment, from fundamentals, to advanced techniques like targeted alpha particle therapy. Uncover the personalized approach revolutionizing oncology. Stay informed on cutting-edge medical innovation by reading down below! #MedicalAdvancements #PrecisionMedicine ⬇️⬇️⬇️⬇️⬇️ https://lnkd.in/gf_n6F_n
-
CAR T cell Therapy - Autoimmunity- Cancer Biology
1moLooking forward to this!